The legacy of Viagra and its creator , copyright, presents a fascinating picture for potential investors. While the iconic drug initially fueled enormous revenues , its exclusivity has expired , leading to competing versions flooding the arena. This reduction in pricing presents a real obstacle for copyright and any portfolio considering a heavy ho